Literature DB >> 15639779

Dopamine D2 agonist priming in intact and dopamine-lesioned rats.

Richard M Kostrzewa1, John P Kostrzewa, Przemyslaw Nowak, Rose A Kostrzewa, Ryszard Brus.   

Abstract

Receptor priming is a recently discovered phenomenon by which receptor agonists produce abrupt and long-lived supersensitization of receptors. Induction of dopamine (DA) D2 receptor supersensitivity by the agonist quinpirole was discovered approximately 15 years ago, and was found to occur consistently if rats were treated repeatedly at daily or weekly or monthly intervals with low or high doses of quinpirole. In this review we summarize and discuss some of the major studies that underlie DA D2 receptor supersensitivity, describe behavioral processes that are known to be altered by DA D2 receptor supersensitivity, and discuss the importance of DA innervation on expression of enhanced behaviors. DA D2 receptor supersensitivity represents one of the neural mechanisms implicated in psychiatric disorders. Also, DA D2 receptor supersensitivity and increased DA D3 receptor expression are associated with motor dyskinesias, as in L-DOPA-treated Parkinson's disease patients. An understanding of receptor priming, a knowledge of the types of behavioral expression associated with DA D2 receptor supersensitivity, and an understanding of mechanisms associated with receptor supersensitization, can lead to improvements in the treatments of psychiatric and neurological disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15639779     DOI: 10.1007/BF03033281

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  29 in total

1.  Is dopamine-agonist induced yawning behavior a D3 mediated event?

Authors:  R M Kostrzewa; R Brus
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

2.  Associational and nonassociational mechanisms in locomotor sensitization to the dopamine agonist quinpirole.

Authors:  H Einat; D Einat; M Allan; H Talangbayan; T Tsafnat; H Szechtman
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

3.  Ontogenetic homologous sensitization to the antinociceptive action of quinpirole in rats.

Authors:  R M Kostrzewa; R Brus; J Kalbfleisch
Journal:  Eur J Pharmacol       Date:  1991-12-17       Impact factor: 4.432

4.  Possible association of increased rat behavioral effects and increased striatal dopamine and norepinephrine levels during the DOPA-potentiation test.

Authors:  M A Spirtes; N P Plotnikoff; R M Kostrzewa; C T Harston; A J Kastin; C W Christensen
Journal:  Pharmacol Biochem Behav       Date:  1976       Impact factor: 3.533

5.  Nicotine blocks quinpirole-induced behavior in rats: psychiatric implications.

Authors:  Y Tizabi; R L Copeland; R Brus; R M Kostrzewa
Journal:  Psychopharmacology (Berl)       Date:  1999-08       Impact factor: 4.530

6.  Ontogenetic quinpirole treatments produce spatial memory deficits and enhance skilled reaching in adult rats.

Authors:  Russell W Brown; Justin T Gass; Richard M Kostrzewa
Journal:  Pharmacol Biochem Behav       Date:  2002-06       Impact factor: 3.533

7.  Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.

Authors:  G R Breese; A A Baumeister; T J McCown; S G Emerick; G D Frye; K Crotty; R A Mueller
Journal:  J Pharmacol Exp Ther       Date:  1984-11       Impact factor: 4.030

8.  Longlasting consequences of chronic treatment with the dopamine agonist quinpirole for the undrugged behavior of rats.

Authors:  H Einat; H Szechtman
Journal:  Behav Brain Res       Date:  1993-03-31       Impact factor: 3.332

9.  Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine.

Authors:  G R Breese; A Baumeister; T C Napier; G D Frye; R A Mueller
Journal:  J Pharmacol Exp Ther       Date:  1985-11       Impact factor: 4.030

10.  Ontogenetic quinpirole treatment induces vertical jumping activity in rats.

Authors:  R M Kostrzewa; J Guo; F P Kostrzewa
Journal:  Eur J Pharmacol       Date:  1993-08-03       Impact factor: 4.432

View more
  11 in total

Review 1.  Stereotypic progressions in psychotic behavior.

Authors:  Richard M Kostrzewa; John P Kostrzewa; Rose Anna Kostrzewa; Florence P Kostrzewa; Ryszard Brus; Przemyslaw Nowak
Journal:  Neurotox Res       Date:  2010-04-22       Impact factor: 3.911

2.  Histamine H(3) receptor ligands modulate L-dopa-evoked behavioral responses and L-dopa derived extracellular dopamine in dopamine-denervated rat striatum.

Authors:  Przemyslaw Nowak; Aleksandra Bortel; Joanna Dabrowska; Izabela Biedka; Grzegorz Slomian; Wojciech Roczniak; Richard M Kostrzewa; Ryszard Brus
Journal:  Neurotox Res       Date:  2008 May-Jun       Impact factor: 3.911

Review 3.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 4.  Dopamine D2 Receptor Supersensitivity as a Spectrum of Neurotoxicity and Status in Psychiatric Disorders.

Authors:  Richard M Kostrzewa; Karolina Wydra; Malgorzata Filip; Cynthia A Crawford; Sanders A McDougall; Russell W Brown; Dasiel O Borroto-Escuela; Kjell Fuxe; Raul R Gainetdinov
Journal:  J Pharmacol Exp Ther       Date:  2018-06-19       Impact factor: 4.030

5.  Neonatal 6-hydroxydopamine lesioning enhances quinpirole-induced vertical jumping in rats that were quinpirole primed during postnatal ontogeny.

Authors:  Richard M Kostrzewa; Florence P Kostrzewa
Journal:  Neurotox Res       Date:  2011-08-19       Impact factor: 3.911

6.  Role of dopamine D3 and serotonin 5-HT 1A receptors in L: -DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Authors:  Manfred Gerlach; Gerd D Bartoszyk; Peter Riederer; Olivia Dean; Maarten van den Buuse
Journal:  J Neural Transm (Vienna)       Date:  2011-01-21       Impact factor: 3.575

Review 7.  Gene-environment interplay in neurogenesis and neurodegeneration.

Authors:  Tomás Palomo; Trevor Archer; Richard J Beninger; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 8.  Neurotoxins and neurotoxic species implicated in neurodegeneration.

Authors:  Juan Segura Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

9.  Perinatal Treatments with the Dopamine D₂-Receptor Agonist Quinpirole Produces Permanent D₂-Receptor Supersensitization: a Model of Schizophrenia.

Authors:  Richard M Kostrzewa; Przemysław Nowak; Ryszard Brus; Russell W Brown
Journal:  Neurochem Res       Date:  2015-11-07       Impact factor: 3.996

10.  Histamine H3 receptor antagonist JNJ-39220675 modulates locomotor responses but not place conditioning by dopaminergic drugs.

Authors:  Jenni Vanhanen; Marja Kinnunen; Saara Nuutinen; Pertti Panula
Journal:  Psychopharmacology (Berl)       Date:  2014-10-12       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.